Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.ConvaTec, a provider of wound therapeutics and ostomy care products, has acquired Unomedical, a provider of single-use medical devices with global operations.
Subscribe to our email newsletter
The combination is expected to create a company with $1.6 billion in annual sales with a significantly expanded global footprint. The combined company will be known as ConvaTec and will be led by current ConvaTec CEO, David Johnson.
ConvaTec will have four business divisions: ostomy care, wound therapeutics, continence & critical care, and infusion devices. Infusion Devices will continue to operate separately. As required by the European Competition Commission, the integration will not include the Unomedical wound care division, which will be divested within the next several months.
With complementary portfolios in acute care and home healthcare, the combined company is expected to be a much larger driving force in the industry, with an expanded offering of products and product-related services for customers around the world.
Mr Johnson said: “As two global healthcare leaders, we are uniquely positioned to build on each other’s strengths. By joining forces, our combined company will be able to offer our customers around the world an unprecedented portfolio of comprehensive best-in-class solutions.”